Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Hereditary Angioedema Therapeutic industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Sanofi
Takeda Pharmaceutical Company Limited
Pharming Group NV
Novartis AG
Ionis Pharmaceuticals
BIOCRYST PHARMACEUTICALS, INC
CENTOGENE AG
KalVista Pharmaceuticals
CSL Limited
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Intravenous
Subcutaneous
Oral
Application:
Hospitals
Clinics
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Hereditary Angioedema Therapeutic Industry Overview
-
1.1.1 Hereditary Angioedema Therapeutic Market Scope and Market Segments
-
1.1.2 Hereditary Angioedema Therapeutic Industry Characteristics
-
1.1.3 Global and China Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Hereditary Angioedema Therapeutic Production Value and Growth Rate (2017-2028)
-
1.2 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Intravenous
-
1.2.2 Subcutaneous
-
1.2.3 Oral
-
1.3 Global Hereditary Angioedema Therapeutic Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Clinics
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Hereditary Angioedema Therapeutic Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Hereditary Angioedema Therapeutic Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Hereditary Angioedema Therapeutic Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Hereditary Angioedema Therapeutic Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Hereditary Angioedema Therapeutic Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Hereditary Angioedema Therapeutic Industry Porter's Five Forces Model Analysis
-
2.2.3 Hereditary Angioedema Therapeutic Industry PEST Analysis
-
2.3 Hereditary Angioedema Therapeutic Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Hereditary Angioedema Therapeutic Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Hereditary Angioedema Therapeutic Industry
Chapter 3 Global and China Hereditary Angioedema Therapeutic Market, by Manufacturer
-
3.1 Global and China Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Hereditary Angioedema Therapeutic Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Hereditary Angioedema Therapeutic Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Hereditary Angioedema Therapeutic Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Hereditary Angioedema Therapeutic Market Top 3 Players
Chapter 4 Global and China Hereditary Angioedema Therapeutic Market, by Type (2017-2028)
-
4.1 Hereditary Angioedema Therapeutic Market Trend, by Type
-
4.2 Global Hereditary Angioedema Therapeutic Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Hereditary Angioedema Therapeutic Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Hereditary Angioedema Therapeutic Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Hereditary Angioedema Therapeutic Price Trend, by Type (2017-2028)
-
4.3 China Hereditary Angioedema Therapeutic Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Hereditary Angioedema Therapeutic Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Hereditary Angioedema Therapeutic Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Hereditary Angioedema Therapeutic Price Trend, by Type (2017-2028)
Chapter 5 Global and China Hereditary Angioedema Therapeutic Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Hereditary Angioedema Therapeutic Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Hereditary Angioedema Therapeutic Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Hereditary Angioedema Therapeutic Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Hereditary Angioedema Therapeutic Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Hereditary Angioedema Therapeutic Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Hereditary Angioedema Therapeutic Market Analysis
-
7.1 North America Hereditary Angioedema Therapeutic Market, by Type
-
7.2 North America Hereditary Angioedema Therapeutic Market, by Application
-
7.3 North America Hereditary Angioedema Therapeutic Market Analysis and Forecast, by Country
-
7.3.1 United States Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Hereditary Angioedema Therapeutic Market Analysis
-
8.1 Europe Hereditary Angioedema Therapeutic Market, by Type
-
8.2 Europe Hereditary Angioedema Therapeutic Market, by Application
-
8.3 Europe Hereditary Angioedema Therapeutic Market Analysis and Forecast, by Country
-
8.3.1 Germany Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Hereditary Angioedema Therapeutic Market Analysis
-
9.1 APAC Hereditary Angioedema Therapeutic Market, by Type
-
9.2 APAC Hereditary Angioedema Therapeutic Market, by Application
-
9.3 APAC Hereditary Angioedema Therapeutic Market Analysis and Forecast, by Country
-
9.3.1 China Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Market Analysis
-
10.1 Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Market, by Type
-
10.2 Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Market, by Application
-
10.3 Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Hereditary Angioedema Therapeutic Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Hereditary Angioedema Therapeutic Company Profiles
-
11.1 Sanofi
-
11.1.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Sanofi Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.1.3 Sanofi Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Takeda Pharmaceutical Company Limited
-
11.2.1 Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.2.3 Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Pharming Group NV
-
11.3.1 Pharming Group NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Pharming Group NV Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.3.3 Pharming Group NV Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Novartis AG
-
11.4.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Novartis AG Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.4.3 Novartis AG Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Ionis Pharmaceuticals
-
11.5.1 Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.5.3 Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 BIOCRYST PHARMACEUTICALS, INC
-
11.6.1 BIOCRYST PHARMACEUTICALS, INC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.6.3 BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 CENTOGENE AG
-
11.7.1 CENTOGENE AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 CENTOGENE AG Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.7.3 CENTOGENE AG Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 KalVista Pharmaceuticals
-
11.8.1 KalVista Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.8.3 KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 CSL Limited
-
11.9.1 CSL Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 CSL Limited Hereditary Angioedema Therapeutic Product Profiles, Application and Specification
-
11.9.3 CSL Limited Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Hereditary Angioedema Therapeutic Industry Investment Prospect and Risk Assessment
-
12.1 Hereditary Angioedema Therapeutic Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Hereditary Angioedema Therapeutic Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Production Value and Growth Rate (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Production Value and Growth Rate (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Intravenous (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Subcutaneous (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Oral (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Clinics (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Hereditary Angioedema Therapeutic Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Hereditary Angioedema Therapeutic Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Hereditary Angioedema Therapeutic Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Hereditary Angioedema Therapeutic Market Share, by Manufacturer in 2021
-
Figure Global and China Hereditary Angioedema Therapeutic Market Share, by Manufacturer in 2022
-
Table Global Hereditary Angioedema Therapeutic Sales Volume, by Type (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Value, by Type (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Value Share, by Type (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Price Trend, by Type (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Volume, by Type (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Value, by Type (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Value Share, by Type (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Price Trend, by Type (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Volume, by Application (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Value, by Application (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Sales Value Share, by Application (2017-2028)
-
Figure Global Hereditary Angioedema Therapeutic Sales Value Share, by Application (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Volume, by Application (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Value, by Application (2017-2028)
-
Table China Hereditary Angioedema Therapeutic Sales Value Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Value Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
Figure North America Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Production, Import, Consumption and Export (2017-2022)
-
Table North America Hereditary Angioedema Therapeutic Sales Volume, by Type (2017-2028)
-
Table North America Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Figure North America Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Table North America Hereditary Angioedema Therapeutic Sales Volume, by Application (2017-2028)
-
Table North America Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure North America Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure United States Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure United States Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Canada Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Table Europe Hereditary Angioedema Therapeutic Sales Volume, by Type (2017-2028)
-
Table Europe Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Figure Europe Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Table Europe Hereditary Angioedema Therapeutic Sales Volume, by Application (2017-2028)
-
Table Europe Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure Europe Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure Germany Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure UK Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure UK Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure France Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure France Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Italy Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Spain Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Poland Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Russia Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Table APAC Hereditary Angioedema Therapeutic Sales Volume, by Type (2017-2028)
-
Table APAC Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Figure APAC Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Table APAC Hereditary Angioedema Therapeutic Sales Volume, by Application (2017-2028)
-
Table APAC Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure APAC Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure China Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Japan Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure India Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure India Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Therapeutic Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Hereditary Angioedema Therapeutic Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Hereditary Angioedema Therapeutic Sales Value and Growth Rate (2017-2028)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Pharmaceutical Company Limited Product Profiles, Application and Specification
-
Table Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pharming Group NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pharming Group NV Product Profiles, Application and Specification
-
Table Pharming Group NV Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ionis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ionis Pharmaceuticals Product Profiles, Application and Specification
-
Table Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BIOCRYST PHARMACEUTICALS, INC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BIOCRYST PHARMACEUTICALS, INC Product Profiles, Application and Specification
-
Table BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CENTOGENE AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CENTOGENE AG Product Profiles, Application and Specification
-
Table CENTOGENE AG Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table KalVista Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table KalVista Pharmaceuticals Product Profiles, Application and Specification
-
Table KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CSL Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Limited Product Profiles, Application and Specification
-
Table CSL Limited Hereditary Angioedema Therapeutic Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
